Explore our highly standardized botanical extracts and pharmaceutical ingredients, prepared under rigorous GMP audits.
Understanding the chemical architecture, therapeutic values, and pharmacodynamics of premium-grade Salvia Miltiorrhiza Diterpenoids.
Tanshinone IIA is a highly lipophilic diterpenoid quinone derived from the roots and rhizomes of Salvia miltiorrhiza (commonly known as Danshen). As one of the primary active markers used for the quality control of Danshen-based preparations, Tanshinone IIA has gained substantial recognition in modern biopharmaceutical applications. Its molecular structure consists of a phenanthrenequinone skeleton, which imparts its signature red-orange crystalline appearance and governs its lipid solubility characteristics.
From a pharmacodynamic perspective, Tanshinone IIA stands out due to its multi-target cardioprotective, anti-inflammatory, and vasodilative properties. In clinical and laboratory contexts, it is widely utilized for its capacity to alleviate oxidative stress by scavenging reactive oxygen species (ROS), protecting vascular endothelial cells from apoptosis, and downregulating the expression of key inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Modern research has also spotlighted its potential in oncology, where it demonstrates an ability to induce apoptosis in cancer cells and inhibit angiogenesis, making it a highly valued candidate for integrated therapeutic strategies.
Standardized formulations range from 10% to 98% HPLC purity. Characterized by a molecular formula of C19H18O3, molecular weight of 294.34 g/mol, and a CAS Registry Number of 568-72-9. It features high lipid solubility and low moisture residue, optimal for stable formulation matrices.
It exhibits a red-orange needle crystal format at high purities. Soluble in organic solvents such as dimethyl sulfoxide (DMSO), ethanol, and ethyl acetate, while being practically insoluble in water. Optimal storage requires airtight, light-resistant containers maintained below 25°C.
Recognized for promoting microcirculation, maintaining coronary artery blood flow, suppressing platelet aggregation, and managing cellular adhesion molecules. It is a critical component for both standard cardiovascular formulations and modern nutraceutical blends.
Historically, Tanshinone IIA extraction relied heavily on heated reflux using ethanol or acetone. While cost-effective, this approach introduces thermal degradation risks and organic solvent residues. Chengdu Chenlv Herb utilizes state-of-the-art Supercritical CO2 Fluid Extraction combined with industrial column chromatography. This process eliminates hazardous solvent exposure, preserves the native chemical profile of the diterpenoids, and yields a product with substantially lower heavy metal footprint and pesticide counts—easily surpassing USP, EP, and ChP monograph requirements.
A comprehensive analysis of agricultural sourcing, manufacturing dynamics, and supply chain security.
The global demand for Tanshinone IIA has shifted from traditional botanical formulations to high-value active pharmaceutical ingredients (APIs) and standardized dietary supplement intermediates. This shift is driven by an aging global population seeking cardiovascular wellness and a rising preference for natural-source medicine supported by peer-reviewed clinical data. Geographically, China remains the leading producer and exporter due to favorable agro-ecological zones for Salvia miltiorrhiza cultivation, particularly in Sichuan, Shandong, and Shaanxi provinces.
However, the global market faces significant supply chain vulnerabilities. Fluctuations in raw root availability, wild harvest depletion, and unstable agricultural practices (such as the misuse of chemical fertilizers and pesticides) frequently cause pricing volatility and quality inconsistencies. To counter these challenges, leading manufacturers have established GAP-compliant (Good Agricultural Practices) cultivation bases. By managing the seed strain selection, soil testing, irrigation, and harvesting schedules, suppliers can ensure a reliable, year-round volume of high-potency roots, buffering global distributors against raw material shortages.
In addition, advanced analytical instrumentation is now standard for global trade. Importers in the United States, Germany, Japan, and South Korea demand rigorous analytical testing profiles, including High-Performance Liquid Chromatography (HPLC) for assay validation, Inductively Coupled Plasma Mass Spectrometry (ICP-MS) for heavy metal profiling, and Gas Chromatography-Mass Spectrometry (GC-MS) for multi-residue pesticide screenings. Achieving compliance with these parameters is the differentiator that defines a top-tier industrial supplier.
Bridging raw extract supply with specific commercial applications to drive innovation in health and wellness sectors.
Providing high-purity (98% HPLC) API-grade Tanshinone IIA. Our powder serves as the starting block for sodium sulfonate derivatives and direct tablet/capsule compressions targeting coronary heart disease, angina pectoris, and myocarditis.
Delivering standardized 10% to 30% Tanshinone IIA powders designed for blend stability and synergistic action in premium cardiovascular wellness capsules, energy stamina complexes, and microcirculation boosters.
Utilizing the anti-inflammatory, anti-acne, and microcirculatory benefits of Tanshinone IIA to formulate advanced topical creams, serums, and dermal repair solutions aiming to soothe redness and accelerate skin recovery.
A premier botanical science enterprise pioneering natural ingredient solutions since 2012.
How we ensure quality, consistency, and technological innovation at every level of our operations.
Creative formulations and extraction systems that elevate your product lines, supported by our continuous technological research.
Eco-friendly packaging and optimized throughput aligned with today's environmental standards and supply deadlines.
End-to-end traceble raw material extraction, promoting green agriculture and minimal impact processing.
Fast turnaround, customizable specifications, and dedicated export documentation processing to meet your project timelines.
A dedicated quality control team supporting you through every testing step, providing COAs, HPLC chromatograms, and allergen statements.
Decades of manufacturing expertise and industrial distribution, ensuring compliance, stability, and product excellence.
Navigating international borders with localized compliance, certified testing, and custom logistics management.
Importing botanical extracts like Tanshinone IIA requires navigating complex regional frameworks. In the United States, FDA regulations demand strict adherence to Dietary Supplement Current Good Manufacturing Practices (cGMP - 21 CFR Part 111). Under these rules, identity testing is mandatory for every batch. European destinations must comply with European Food Safety Authority (EFSA) guidance on novel foods, as well as strict limits on polycyclic aromatic hydrocarbons (PAHs) and heavy metals. Meanwhile, East Asian markets (such as South Korea's MFDS and Japan's MHLW) maintain their own distinct pharmacopeia standards (KHP and JP).
Chengdu Chenlv Herb addresses these regional variations by providing localized documentation packs. We provide comprehensive safety folders, including detailed flowcharts, allergen declarations, BSE/TSE-free declarations, and irradiation-free statements. Our regulatory affairs team assists clients in submitting New Dietary Ingredient (NDI) notifications in the US and Novel Food applications in Europe, minimizing customs clearance delays and supporting market entry.
Tailoring extract delivery and specifications to meet distinct industrial applications globally.
Driven by the concept of "homology of medicine and food" and modern health needs, plant extracts have gradually become the core raw materials for the development of health care products due to their natural, green and safe characteristics.
Read More
From herbal formulas recorded in ancient books to modern innovative drugs, plant extracts occupy the prominent position in the pharmaceutical industry due to their natural active ingredients and unique pharmacological effects.
Read More
With consumers' pursuit of natural, safe, and sustainable skincare concepts, plant extracts have become a new favorite in the cosmetics industry due to their mildness, versatility, and biocompatibility, bringing new solutions for skin care.
Read More
Plant extracts have shown great potential in improving animal health, enhancing production performance and optimizing culture benefits, and are gradually becoming a research hotspot and new favorite in the field of animal nutrition.
Read MoreThe convergence of plant chemistry, nanotechnology, and green refining technologies.
The primary technological challenge for Tanshinone IIA has always been its low bioavailability. Due to its hydrophobic structure, oral administration results in limited gastrointestinal absorption and rapid first-pass clearance. To address this limitation, Chengdu Chenlv Herb's R&D pipeline is focusing on advanced micro-encapsulation techniques and self-microemulsifying drug delivery systems (SMEDDS). By trapping Tanshinone IIA within a hydrophilic nanocarrier matrix, we can increase its solubility in gastric and intestinal fluids, enhancing cellular uptake and therapeutic efficacy.
Looking to the future, we are actively exploring the convergence of traditional botanical extraction with synthetic biology. Using engineered yeast strains to ferment precursors of Tanshinone IIA offers a sustainable, weather-independent production method. While botanical farming remains our primary supply line, developing synthetic biology capabilities ensures we can meet future high-volume demands while reducing land use and protecting biodiversity. This hybrid approach guarantees long-term supply chain security for partners in the pharmaceutical and wellness fields.
Collaborative engineering from early-stage laboratory specifications to commercial-scale volume production.
01
Communicate with customers to determine product specifications, regulatory requirements, and target packaging formats.
02
Provide a comprehensive and transparent proposal and commercial quotation based on customer requirements.
03
Sign a contract to further discuss the details of cooperation, including milestones, parameters, and supply timelines.
04
Prepare customized samples and pilot-run validation records in our R&D facility for customer testing and verification.
05
After customers confirm the samples, the factory schedules the production order in our GMP-compliant facility.
06
The factory tests the products and issues a comprehensive Certificate of Analysis (COA) containing HPLC, heavy metals, and micro tests.
07
Deliver finished products to customers via temperature-controlled shipping methods, with complete export declarations and safety compliance folders.
Answering common questions regarding chemistry, extraction technology, shelf-life, and sourcing standards.
Stay informed with the latest research milestones, agricultural trends, and international trade events.
Recently, the market price of Citrus aurantium raw materials in China has been on the rise, drawing significant attention from the industry. As the new production season (May-June) comes to an end and new supplies gradually enter the market, price fluctuations have become a focal point due to supply and demand dynamics and cost considerations.
As a 'calling card' for leading China's pharmaceutical industry onto the global stage, the 23rd China Pharmaceutical Raw Materials Exhibition (CPHI China 2025) will join hands with the 18th China Pharmaceutical Machinery to present the latest innovations.
The 92nd China International Pharmaceutical Raw Materials / Intermediates / Packaging / Equipment Fair (API China) will grandly open at the China Import and Export Fair Exhibition Hall in Guangzhou from May 21-23,2025.
For inquiries about our products or price list, please leave your email with us and we will be in touch within 24 hours.
Contact UsBrowse our extensive selection of plant-derived active substances, engineered for safety, purity, and clinical efficacy.